LNTH
Lantheus Holdings, Inc.
LNTH has lower modeled downside risk, despite its lower overall score.
OSCR
Oscar Health, Inc.
OSCR has the edge over LNTH overall, supported by stronger fundamentals.
LNTH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Strong |
LNTH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
LNTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $62.87 | -38% |
| Forward | 16x | $101 | — |
| Fair | 24x | $98.08 | -3.1% |
| Current | 25x | $101 | — |
| Expensive | 141x | $579 | +472% |
Historical ranges are pointers, not guarantees.
LNTH's PE is in its fair range at 25x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over LNTH in the historical PE scenario, which offers more potential upside but is not a forecast.
LNTH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for LNTH, with profitability improving. However, they disagree widely on these estimates.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
LNTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.35 | +55% |
| Q3 2026 | $4.10 | +73% |
| Q2 2026 | $4.18 | +11% |
| Q1 2026 | $4.19 | +19% |
| Q4 2025 | $3.41 | -22% |
| Q3 2025 | $2.37 | -61% |
| Q2 2025 | $3.75 | -39% |
| Q1 2025 | $3.51 | -46% |
| Q4 2024 | $4.36 | -6.2% |
LNTH's earnings per share have fallen from their peak: $4.10 over the past year, against $6.56 in early 2024.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over LNTH on earnings, with more consistent year-over-year improvement.
LNTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $389.9M | +1.5% |
| Q2 2026 | $388.2M | +2.7% |
| Q1 2026 | $377.3M | +1.2% |
| Q4 2025 | $406.8M | +4% |
| Q3 2025 | $384M | +1.4% |
| Q2 2025 | $378M | -4.1% |
| Q1 2025 | $372.8M | +0.8% |
| Q4 2024 | $391.1M | +10% |
LNTH's revenue grew through 2024 and has held roughly level since: $390M last quarter, up 1.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | -3.1 points |
| Q2 2026 | 26% | +2.6 points |
| Q1 2026 | 22% | -5.8 points |
| Q4 2025 | 19% | -10 points |
| Q3 2025 | 11% | -24 points |
| Q2 2025 | 23% | -2.8 points |
| Q1 2025 | 27% | -1.4 points |
| Q4 2024 | 29% | -9.7 points |
LNTH has the edge over OSCR on profitability, with a higher operating margin.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over LNTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
LNTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $99.9M | +5.6% |
| Q2 2026 | $89.9M | +14% |
| Q1 2026 | $121.9M | +23% |
| Q4 2025 | $81.4M | -42% |
| Q3 2025 | $94.7M | -41% |
| Q2 2025 | $79.1M | +7.6% |
| Q1 2025 | $98.8M | -17% |
| Q4 2024 | $141.4M | +26% |
LNTH generated $393M in free cash flow over the past year, down 5.1% from the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over LNTH on cash flow, with more consistent year-over-year improvement.
LNTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +895K shares |
| 1 year | +1.1% | +750K shares |
| 3 years | -2.3% | -1.6M shares |
| 5 years | +1.2% | +790K shares |
| Available history | +71% | +28.3M shares |
LNTH has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $100M |
| Q3 2025 | $100M |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LNTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
LNTH has more cash than debt.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over LNTH on leverage, with a lower net debt burden relative to earnings.
LNTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.4 | Neutral |
| Stochastic | 43.2 | Neutral |
LNTH's weekly RSI is 60 (neutral) and its Stochastic is 43 (neutral).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
LNTH PE vs Healthcare Sector
| Metric | LNTH | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 26x | 4.4% below |
| PE % | 55 | 29 | 26 pts above |
LNTH is trading at 25x earnings, in line with the Healthcare sector's median of 26x.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over LNTH on valuation relative to its sector.
LNTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.2 | 1% above |
| 20 week MA | $101.7 | 0.4% below |
| 50 week MA | $88.7 | 14% above |
| 100 week MA | $82.7 | 22% above |
| 200 week MA | $80.9 | 25% above |
LNTH's trend is mixed: it's above four of its five weekly moving averages, and 25% above its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over LNTH on trend strength, trading above more of its moving averages.
LNTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.3 | $14.7 | -27% |
| 2021 | $14.7 | $29.4 | +100% |
| 2022 | $29.4 | $50.6 | +72% |
| 2023 | $50.6 | $62.0 | +22% |
| 2024 | $62.0 | $92.1 | +48% |
| 2025 | $92.1 | $66.7 | -28% |
| 2026 YTD | $66.7 | $101.3 | +52% |
LNTH has finished higher in four of the last six years, two of them by more than 50%. It's up 52% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over LNTH on returns for 2026, with the stronger performance.